Articles by Ryan McBride
In an effort to advance drug and disease research in children, a unit of the National Institutes of Health aims to fund studies of biomarkers of adult ailments for use in pediatric patients.
Researchers garnered upbeat results from a large clinical trial of a genetic test for organ rejection in patients with transplanted kidneys.
Scientists found a molecular clue in their search for ways to wipe out one of the most devastating tropical diseases on earth. Known as river blindness, Onchocerciasis is a leading cause of vision loss, especially in the developing world. Yet the disease leaves behind a biomarker in the urine of patients that could easily identify those in need of treatment.
Scientists have tied the activity of a life-supporting protein for cells to poor outcomes in patients with the blood cancer multiple myeloma, according to ScienceDaily. And their findings could aid clinicians in diagnosing patients while exposing a target for new therapies.
The U.S. Supreme Court is going to take up a case that could have a major impact on the patentability of genes used in diagnostics.
Seaside Therapeutics wants to home in on which autism patients are likely to respond to its lead drug, STX-209 (arbaclofen). The Cambridge, MA-based biotech won a $2 million award with funds from Autism Speaks, a major research funder and advocate for awareness of autism spectrum disorders (ASDs).